Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Penumbra, Inc. Common Stock (NY: PEN )

274.49 +13.86 (+5.32%)
Streaming Delayed Price Updated: 12:53 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Penumbra, Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >
ResMed Among Top Stocks For Recent And Long-Term Profit Growth
A Relative Strength Rating upgrade for ResMed shows improving technical performance. Will it continue? 
Via Investor's Business Daily
3 Mid-Cap Stocks in Hot Water
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with... 
Via StockStory
Merit Medical Systems (MMSI) Q4 Earnings Report Preview: What To Look For
Medical device company Merit Medical Systems (NASDAQ:MMSI) will be announcing earnings results tomorrow after market close. Here’s what to look for. 
Via StockStory
Artivion (AORT) Q4 Earnings: What To Expect
Medical device company Artivion (NYSE:AORT) will be reporting results tomorrow after the bell. Here’s what you need to know. 
Via StockStory
Stroke Device Maker Penumbra Stock Surges On Earnings Beat, Analysts Boost Price Forecasts After Upbeat 2025 Outlook
Penumbra stock climbs after Q4 earnings surpass expectations, with sales up 10.8% Y/Y. Analysts raise price targets as the company projects strong 2025 growth. 
Via Benzinga
Topics Earnings
Exposures Financial
10 Analysts Assess Penumbra: What You Need To Know
Via Benzinga
Peering Into Penumbra's Recent Short Interest
Via Benzinga
(PEN) - Analyzing Penumbra's Short Interest
Via Benzinga
Why Penumbra (PEN) Stock Is Trading Up Today
Shares of medical device company Penumbra (NYSE:PEN) jumped 13.6% in the afternoon session after the company reported impressive fourth-quarter 2024 results, which blew past analysts' constant currency... 
Via StockStory
Garmin Posts Better-Than-Expected Results, Joins SolarEdge Technologies, Compass, Appian And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Profit Machine Penumbra Surges On Solid Fourth-Quarter Beat, But Guidance Lags
The company easily beat fourth-quarter expectations. But there was one drawback in its report. 
Via Investor's Business Daily
Price Over Earnings Overview: Penumbra
Via Benzinga
12 Analysts Assess Penumbra: What You Need To Know
Via Benzinga
(PEN) - Analyzing Penumbra's Short Interest
Via Benzinga
Breaking Down Penumbra: 11 Analysts Share Their Views
Via Benzinga
Penumbra’s (NYSE:PEN) Q4 Sales Beat Estimates
Medical device company Penumbra (NYSE:PEN) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 10.8% year on year to $315.5 million. On the other hand, the company’s... 
Via StockStory
Topics Earnings
Exposures Financial
Penumbra (PEN) Reports Q4: Everything You Need To Know Ahead Of Earnings
Medical device company Penumbra (NYSE:PEN) will be reporting earnings tomorrow afternoon. Here’s what you need to know. 
Via StockStory
Artivion (NYSE:AORT) Q3 Earnings: Leading The Medical Devices & Supplies - Cardiology, Neurology, Vascular Pack
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including Artivion (NYSE:AORT) and its peers. 
Via StockStory
Unpacking Q3 Earnings: ICU Medical (NASDAQ:ICUI) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including... 
Via StockStory
How Is The Market Feeling About Penumbra?
Via Benzinga
Earnings Scheduled For February 18, 2025
Via Benzinga
Spotting Winners: Penumbra (NYSE:PEN) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q3
Looking back on medical devices & supplies - cardiology, neurology, vascular stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Penumbra (NYSE:PEN) and its peers. 
Via StockStory
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Merit Medical Systems (NASDAQ:MMSI) Vs The Rest
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including Merit Medical Systems... 
Via StockStory
This MongoDB Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Inspire Medical's Sleep Innovations Driving Big Gains
Inspire Medical, which makes innovative apnea relief devices, hit a key performance benchmark as its Relative Strength Rating jumped to 81. 
Via Investor's Business Daily
UniFirst, Getty Images, Shutterstock And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Inari Medical Catapults 30% On Rumored Stryker Takeover
Inari is best-known for its series of catheter-like devices that remove blood clots. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst
Oppenheimer predicts growth for Penumbra Inc in MT market. Analyst initiates coverage with Outperform rating and $275 target price. 
Via Benzinga
This Elastic Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.